United States

Aegerion Pharmaceuticals Inc (AEGR)

Track

Ticker: AEGR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 13 Sep 2016
Value US$4,047,288.40 | Price 195.39 | Shares 12,887 (+18.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-09-14 2016-09-13 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
12,887 +18.8%
195.39
US$4,047,288 		12,887 +18.8% 195.39 US$4,047,288
2016-09-12 2016-09-12 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
75,813 +36.0%
32.58
US$2,336,246 		75,813 +36.0% 32.58 US$2,336,246
2016-09-12 2016-09-12 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
66,947 +39.2%
475.32
US$1,559,524 		66,947 +39.2% 475.32 US$1,559,524
2016-09-12 2016-09-09 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 +2.5%
1.60
US$159,500 		100,000 +2.5% 1.60 US$159,500
2015-11-13 2015-11-11 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
35,000 +0.9%
10.96
US$383,600 		35,000 +0.9% 10.96 US$383,600
2015-11-13 2015-11-11 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
5,100 +0.1%
10.99
US$56,049 		5,100 +0.1% 10.99 US$56,049
2014-08-20 2014-08-19 B Purchase Fitzpatrick Mark J.

Chief Financial Officer

Officer
1,150 +13.8%
30.64
US$35,236 		1,150 +13.8% 30.64 US$35,236
2014-07-31 2014-07-31 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
2,300 +3.0%
34.37
US$79,051 		2,300 +3.0% 34.37 US$79,051
2014-07-31 2014-07-31 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
7,700 +11.1%
33.44
US$257,488 		7,700 +11.1% 33.44 US$257,488
2014-06-04 2014-06-03 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
10,000 +16.8%
30.12
US$301,200 		10,000 +16.8% 30.12 US$301,200
2014-05-27 2014-05-27 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
10,000 +20.2%
31.59
US$315,900 		10,000 +20.2% 31.59 US$315,900
2014-05-21 2014-05-20 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
10,000 +30.3%
30.53
US$305,300 		10,000 +30.3% 30.53 US$305,300
2014-05-09 2014-05-08 B Purchase VANLENT ANNE Non-Executive Director
52 +1.3%
35.29
US$1,835 		52 +1.3% 35.29 US$1,835
2014-05-09 2014-05-08 B Purchase VANLENT ANNE Non-Executive Director
1,948 +97.4%
34.33
US$66,875 		1,948 +97.4% 34.33 US$66,875
2014-05-09 2014-05-08 B Purchase VANLENT ANNE Non-Executive Director
2,000 +inf%
33.20
US$66,400 		2,000 +inf% 33.20 US$66,400
2014-05-08 2014-05-08 B Purchase Beer Marc D

Chief Executive Officer

Executive Director
30,000 +1000.0%
35.31
US$1,059,300 		30,000 +1000.0% 35.31 US$1,059,300
2014-05-01 2014-04-30 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,171 -100.0%
43.90
US$51,407 		1,171 -100.0% 43.90 US$51,407
2014-05-01 2014-04-30 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,079 -48.0%
43.18
US$46,591 		1,079 -48.0% 43.18 US$46,591
2014-04-02 2014-03-31 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
100 -100.0%
47.20
US$4,720 		100 -100.0% 47.20 US$4,720
2014-04-02 2014-03-31 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,001 -90.9%
46.51
US$46,557 		1,001 -90.9% 46.51 US$46,557
2014-04-02 2014-03-31 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,149 -51.1%
45.84
US$52,670 		1,149 -51.1% 45.84 US$52,670
2014-03-18 2014-03-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
800 -100.0%
51.98
US$41,584 		800 -100.0% 51.98 US$41,584
2014-03-18 2014-03-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
900 -52.9%
51.31
US$46,179 		900 -52.9% 51.31 US$46,179
2014-03-18 2014-03-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
300 -15.0%
49.69
US$14,907 		300 -15.0% 49.69 US$14,907
2014-02-18 2014-02-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
500 -100.0%
64.52
US$32,260 		500 -100.0% 64.52 US$32,260
2014-02-18 2014-02-14 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,500 -75.0%
63.14
US$94,710 		1,500 -75.0% 63.14 US$94,710
2014-02-12 2014-02-11 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
2,250 -100.0%
67.00
US$150,750 		2,250 -100.0% 67.00 US$150,750
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
486 -7.7%
64.69
US$31,439 		486 -7.7% 64.69 US$31,439
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
900 -12.4%
63.72
US$57,348 		900 -12.4% 63.72 US$57,348
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
2,814 -28.0%
62.94
US$177,113 		2,814 -28.0% 62.94 US$177,113
2014-02-12 2014-02-10 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
3,300 -24.7%
61.71
US$203,643 		3,300 -24.7% 61.71 US$203,643
2014-01-21 2014-01-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
100 -100.0%
59.51
US$5,951 		100 -100.0% 59.51 US$5,951
2014-01-21 2014-01-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,900 -95.0%
58.59
US$111,318 		1,900 -95.0% 58.59 US$111,318
2014-01-06 2014-01-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
600 -100.0%
71.41
US$42,847 		600 -100.0% 71.41 US$42,847
2014-01-06 2014-01-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
400 -40.0%
70.22
US$28,087 		400 -40.0% 70.22 US$28,087
2014-01-06 2014-01-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,350 -100.0%
71.42
US$96,414 		1,350 -100.0% 71.42 US$96,414
2014-01-06 2014-01-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
900 -40.0%
70.65
US$63,584 		900 -40.0% 70.65 US$63,584
2013-12-17 2013-12-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
200 -100.0%
67.38
US$13,476 		200 -100.0% 67.38 US$13,476
2013-12-17 2013-12-16 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,800 -90.0%
66.23
US$119,211 		1,800 -90.0% 66.23 US$119,211
2013-12-04 2013-12-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
700 -100.0%
71.10
US$49,769 		700 -100.0% 71.10 US$49,769
2013-12-04 2013-12-02 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,550 -68.9%
70.10
US$108,654 		1,550 -68.9% 70.10 US$108,654
2013-12-04 2013-12-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
600 -100.0%
71.20
US$42,718 		600 -100.0% 71.20 US$42,718
2013-12-04 2013-12-02 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
2,400 -80.0%
70.23
US$168,549 		2,400 -80.0% 70.23 US$168,549
2013-11-19 2013-11-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
500 -100.0%
77.63
US$38,817 		500 -100.0% 77.63 US$38,817
2013-11-19 2013-11-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,011 -66.9%
75.89
US$76,726 		1,011 -66.9% 75.89 US$76,726
2013-11-19 2013-11-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
489 -24.4%
74.93
US$36,639 		489 -24.4% 74.93 US$36,639
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
1,800 -37.5%
80.03
US$144,057 		1,800 -37.5% 80.03 US$144,057
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
4,478 -48.3%
79.34
US$355,300 		4,478 -48.3% 79.34 US$355,300
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
622 -6.3%
78.38
US$48,755 		622 -6.3% 78.38 US$48,755
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
200 -2.0%
76.14
US$15,228 		200 -2.0% 76.14 US$15,228
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
200 -1.9%
74.43
US$14,886 		200 -1.9% 74.43 US$14,886
2013-11-13 2013-11-11 PlS Planned sale Fitzpatrick Mark J.

Chief Financial Officer

Officer
200 -1.9%
73.01
US$14,602 		200 -1.9% 73.01 US$14,602
2013-11-05 2013-11-01 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
100 -100.0%
84.34
US$8,434 		100 -100.0% 84.34 US$8,434
2013-11-05 2013-11-01 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
2,000 -95.2%
83.59
US$167,180 		2,000 -95.2% 83.59 US$167,180
2013-11-05 2013-11-01 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,400 -40.0%
82.76
US$115,867 		1,400 -40.0% 82.76 US$115,867
2013-11-05 2013-11-01 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
400 -100.0%
83.99
US$33,597 		400 -100.0% 83.99 US$33,597
2013-11-05 2013-11-01 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
1,550 -79.5%
83.22
US$128,994 		1,550 -79.5% 83.22 US$128,994
2013-11-05 2013-11-01 PlS Planned sale Fraser Craig

Pres., US/Int. Comm. & Manuf.

Officer
300 -13.3%
82.28
US$24,684 		300 -13.3% 82.28 US$24,684
2013-11-05 2013-11-01 PlS Planned sale Carter Martha J.

Chief Regulatory Officer & SVP

Officer
5,000 -76.9%
82.81
US$414,050 		5,000 -76.9% 82.81 US$414,050
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
1,200 -0.6%
99.18
US$119,016 		1,200 -0.6% 99.18 US$119,016
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
300 -0.2%
95.90
US$28,770 		300 -0.2% 95.90 US$28,770
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
200 -0.1%
94.25
US$18,850 		200 -0.1% 94.25 US$18,850
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
400 -0.2%
93.00
US$37,200 		400 -0.2% 93.00 US$37,200
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
700 -0.4%
92.03
US$64,421 		700 -0.4% 92.03 US$64,421
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,500 -1.2%
91.21
US$228,031 		2,500 -1.2% 91.21 US$228,031
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,700 -1.3%
89.85
US$242,592 		2,700 -1.3% 89.85 US$242,592
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
3,800 -1.8%
89.01
US$338,243 		3,800 -1.8% 89.01 US$338,243
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
6,019 -2.8%
87.83
US$528,619 		6,019 -2.8% 87.83 US$528,619
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
10,000 -4.5%
87.08
US$870,752 		10,000 -4.5% 87.08 US$870,752
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,314 -1.0%
85.94
US$198,860 		2,314 -1.0% 85.94 US$198,860
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
7,067 -3.0%
85.00
US$600,689 		7,067 -3.0% 85.00 US$600,689
2013-10-31 2013-10-30 PlS Planned sale Beer Marc D

Chief Executive Officer

Executive Director
2,800 -1.2%
84.15
US$235,621 		2,800 -1.2% 84.15 US$235,621
2013-10-31 2013-10-29 PlS Planned sale SMITH SANDFORD D Non-Executive Director
2,502 -100.0%
95.00
US$237,690 		2,502 -100.0% 95.00 US$237,690
2013-10-16 2013-10-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,000 -100.0%
80.71
US$80,709 		1,000 -100.0% 80.71 US$80,709
2013-10-16 2013-10-15 PlS Planned sale Sumeray Mark

Chief Medical Officer

Officer
1,000 -50.0%
79.95
US$79,950 		1,000 -50.0% 79.95 US$79,950
Explore more

More insider trading research around Aegerion Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America